RS 56812 hydrochloride

CAS No. 143339-12-2

RS 56812 hydrochloride( —— )

Catalog No. M33916 CAS No. 143339-12-2

RS 56812 hydrochloride is a 5-HT3 receptor antagonist and agonist, and may be used in the study of cognitive disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 79 In Stock
5MG 129 In Stock
10MG 188 In Stock
25MG 440 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RS 56812 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    RS 56812 hydrochloride is a 5-HT3 receptor antagonist and agonist, and may be used in the study of cognitive disorders.
  • Description
    RS 56812 hydrochloride is a 5-HT3 receptor antagonist and agonist, and may be used in the study of cognitive disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    143339-12-2
  • Formula Weight
    347.84
  • Molecular Formula
    C18H22ClN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(N[C@@H]1C2(CCN(C1)CC2)[H])=O)(=O)C=3C=4C(N(C)C3)=CC=CC4.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Serazapine

    Serazapine is a highly specific serotonin (5-HT2) binding inhibitor with anxiolytic activity for the treatment of anxiety disorders.

  • Alosetron hydrochlor...

    A potent and selective 5-HT3 receptor antagonist has been shown to be beneficial in the treatment of irritable bowel syndrome.

  • Itasetron

    Itasetron (U 98079A) is a 5-hydroxytryptamine 3-receptor antagonist used to prevent age-related memory deficits in rats.Itasetron's antiemetic activity in animal models of cancer chemotherapy and radiation therapy may be useful in the study of amnesia.